Business Description
Medicover AB
ISIN : SE0009778848
Share Class Description:
LTS:0RPS: Class BCompare
Compare
Traded in other countries / regions
MCOV B.Sweden5M0B.Germany0RPS.UKMCVEY.USA IPO Date
2017-05-25Description
Medicover AB is an international healthcare and diagnostic services, provider. It offers a broad spectrum of healthcare services via an extensive network of ambulatory clinics, hospitals, specialty-care facilities, and laboratories. The company offers its services through two segments; Diagnostic Services offer a broad range of laboratory testing in all clinical pathology areas in Germany, Romania, Poland, and Ukraine, and Healthcare Services offer high-quality care based on an Integrated Healthcare Model and Fee-For-Service in Poland, India, and Romania. It generates maximum revenue from the Healthcare Services segment. Geographically, it derives a majority of its revenue from Poland and also has a presence in Romania; Germany; Ukraine; India, and Other Countries.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.06 | |||||
| Equity-to-Asset | 0.26 | |||||
| Debt-to-Equity | 2.02 | |||||
| Debt-to-EBITDA | 3.8 | |||||
| Interest Coverage | 1.19 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 1.82 | |||||
| Beneish M-Score | -2.76 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 22.2 | |||||
| 3-Year EBITDA Growth Rate | 20.9 | |||||
| 3-Year EPS without NRI Growth Rate | -25 | |||||
| 3-Year FCF Growth Rate | 6 | |||||
| 3-Year Book Growth Rate | 6.5 | |||||
| Future 3-5Y Total Revenue Growth Rate | 15.79 |
Momentum Rank
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.76 | |||||
| Quick Ratio | 0.64 | |||||
| Cash Ratio | 0.13 | |||||
| Days Inventory | 14.56 | |||||
| Days Sales Outstanding | 42.59 | |||||
| Days Payable | 36.71 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -0.3 | |||||
| Shareholder Yield % | -6.48 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 20.6 | |||||
| Operating Margin % | 3.51 | |||||
| Net Margin % | 0.99 | |||||
| FCF Margin % | 5.45 | |||||
| ROE % | 3.65 | |||||
| ROA % | 0.94 | |||||
| ROIC % | 2.72 | |||||
| ROC (Joel Greenblatt) % | 8.77 | |||||
| ROCE % | 5.23 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 98.35 | |||||
| PE Ratio without NRI | 98.35 | |||||
| Shiller PE Ratio | 63.92 | |||||
| Price-to-Owner-Earnings | 13.84 | |||||
| PEG Ratio | 4.62 | |||||
| PS Ratio | 0.98 | |||||
| PB Ratio | 3.54 | |||||
| Price-to-Free-Cash-Flow | 17.99 | |||||
| Price-to-Operating-Cash-Flow | 8.34 | |||||
| EV-to-EBIT | 36.08 | |||||
| EV-to-EBITDA | 10.5 | |||||
| EV-to-Revenue | 1.55 | |||||
| EV-to-FCF | 28.05 | |||||
| Price-to-Projected-FCF | 1.39 | |||||
| Price-to-Peter-Lynch-Fair-Value | 4.42 | |||||
| Earnings Yield (Greenblatt) % | 2.78 | |||||
| FCF Yield % | 5.44 | |||||
| Forward Rate of Return (Yacktman) % | 23.72 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Medicover AB Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | 20,036.294 | ||
| EPS (TTM) (kr) | 1.334 | ||
| Beta | 0.24 | ||
| Volatility % | 0.51 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR (kr) | 0 | ||
| 20-Day SMA (kr) | 266.5 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (kr) | 266.5 - 266.5 | ||
| Shares Outstanding (Mil) | 149.65 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Medicover AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Medicover AB Stock Events
| Event | Date | Price(kr) | ||
|---|---|---|---|---|
| No Event Data | ||||
Medicover AB Frequently Asked Questions
What is Medicover AB(LTS:0RPS)'s stock price today?
The current price of LTS:0RPS is kr266.50. The 52 week high of LTS:0RPS is kr266.50 and 52 week low is kr266.50.
When is next earnings date of Medicover AB(LTS:0RPS)?
The next earnings date of Medicover AB(LTS:0RPS) is 2024-04-26.
Does Medicover AB(LTS:0RPS) pay dividends? If so, how much?
Medicover AB(LTS:0RPS) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers